Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Discontinuation of Cardiac Devices at or Near an Adult Patient's End of Life.
Journal: Cardiology in review
Published: September 16, 2024
The Role of Palliative Care in Cardiovascular Disease.
Journal: Cardiology in review
Published: January 03, 2024
Criteria That Promote Timely Referral to Specialist Palliative Care for Patients With Advanced Heart Failure.
Journal: Journal of cardiac failure
Published: June 12, 2023
Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach.
Journal: Journal of the American College of Cardiology
Published: August 31, 2022
Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
Journal: Journal of the American College of Cardiology
Published: March 23, 2022
Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.
Journal: Pharmacology & therapeutics
Published: May 11, 2021
The pivotal role of heme Oxygenase-1 in reversing the pathophysiology and systemic complications of NAFLD.
Journal: Archives of biochemistry and biophysics
Published: October 06, 2020
Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review.
Journal: Circulation. Heart failure
Published: September 09, 2020
Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease.
Journal: Antioxidants & redox signaling
Published: January 01, 2020
Cardioprotective Heme Oxygenase-1-PGC1α Signaling in Epicardial Fat Attenuates Cardiovascular Risk in Humans as in Obese Mice.
Journal: Obesity (Silver Spring, Md.)
Published: May 09, 2019
CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy via PGC-1 α Activation.
Journal: Cardiovascular pharmacology: open access
Published: May 01, 2018
EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter.
Journal: Prostaglandins & other lipid mediators
Published: November 21, 2017
Last Updated: 09/26/2026